Risk of Anemia in Patients with Newly Identified Chronic Kidney Disease - A Population-Based Cohort Study

Søren Viborg Vestergaard1, Uffe Heide-Jørgensen1, Heleen van Haalen2

  • 1Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark.

Clinical Epidemiology
|September 28, 2020
PubMed

Insights

Patients with newly identified chronic kidney disease (CKD) face a high risk of developing anemia, with the risk increasing significantly as CKD progresses. Early awareness and monitoring are crucial for managing this common complication.

Area of Science:

  • Nephrology
  • Hematology
  • Epidemiology

Background:

  • Anemia is a common complication in chronic kidney disease (CKD).
  • The longitudinal risk of anemia in patients with newly diagnosed CKD remains largely unknown.
  • Understanding this risk is crucial for timely intervention and patient management.

Purpose of the Study:

  • To investigate the longitudinal risk of developing anemia in patients with newly identified stages 3-5 of chronic kidney disease.
  • To quantify the cumulative incidence and hazard ratios of anemia based on CKD stage.

Main Methods:

  • A population-based cohort study was conducted using data from Northern Denmark (2009-2016).
  • Included were adult patients with newly identified CKD stages 3-5 (eGFR <60 mL/min/1.73m²).
  • Anemia risk was calculated using cumulative incidence and Cox regression analyses.

Main Results:

  • Over 55,000 individuals with newly identified CKD were analyzed.
  • Anemia developed in 42.3% within one year and 67.7% within five years.
  • Anemia risk and hazard ratios increased substantially with higher CKD stages, with CKD stage 5 showing a 5.42-fold increased risk compared to stage 3a.

Conclusions:

  • Newly identified CKD stages 3-5 are associated with a substantial and progressive risk of anemia.
  • The risk of anemia escalates with increasing CKD severity.
  • Clinical vigilance for anemia is essential in patients with newly diagnosed or advanced CKD.
Abstract

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
402
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
393
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
181
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
242
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
550
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
357